Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery

Author(s): Azadeh Manayi, Marjan Nikan, Navid Nobakht-Haghighi, Mohammad Abdollahi*.

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 37 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

Ursolic acid, a natural pentacyclic triterpenoid is commonly found in plants and foods with promising biological and pharmacological activities. The compound has been under the attention of researchers due to its considerable anticancer effects through suppression of differentiation, angiogenesis, invasion, and metastasis of tumor cells via different pathways with low toxicity. Bioavailability of ursolic acid is poor due to poor solubility of the compound in water. Low bioavailability and short plasma half-life of ursolic acid along with non-specific distribution in the body are considered as impediments in the therapeutic development of the compound. Nano-drug delivery systems may improve the pharmacokinetic, bioavailability, and therapeutic activity of some medicines. The present review has focused on recent developments regarding nano-drug delivery systems of ursolic acid in cancer therapy.

Keywords: Bioavailability, Cancer, Nanomedicine, Natural compounds, Ursolic acid, Review.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 37
Year: 2018
Page: [4866 - 4875]
Pages: 10
DOI: 10.2174/0929867324666170713102918
Price: $58

Article Metrics

PDF: 18
HTML: 1